DLGAP1 and central nervous system cancer: Functionally, DLGAP1-AS1 overexpression promoted the proliferation, migration, invasion, and EMT of glioma cells, while its knockdown exerted opposite effects, indicating that DLGAP1-AS1 is a novel oncogenic lncRNA in glioma and might be a promising therapeutic target.